Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/113905

Beta release

Statistics of A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Statistics for this year
PeriodVisitsDownloads
202600
Statistics for the last 3 months
PeriodVisitsDownloads
2026-0300
2026-0400
2026-0500